These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 12569581)
1. Antiproliferative effects of the histone deacetylase inhibitor FR901228 on small-cell lung cancer lines and drug-resistant sublines. Tsurutani J; Soda H; Oka M; Suenaga M; Doi S; Nakamura Y; Nakatomi K; Shiozawa K; Amada YY; Kamihira S; Kohno S Int J Cancer; 2003 Mar; 104(2):238-42. PubMed ID: 12569581 [TBL] [Abstract][Full Text] [Related]
2. Histone deacetylase inhibitors suppress telomerase reverse transcriptase mRNA expression in prostate cancer cells. Suenaga M; Soda H; Oka M; Yamaguchi A; Nakatomi K; Shiozawa K; Kawabata S; Kasai T; Yamada Y; Kamihira S; Tei C; Kohno S Int J Cancer; 2002 Feb; 97(5):621-5. PubMed ID: 11807787 [TBL] [Abstract][Full Text] [Related]
3. FR901228, a novel histone deacetylase inhibitor, induces cell cycle arrest and subsequent apoptosis in refractory human pancreatic cancer cells. Sato N; Ohta T; Kitagawa H; Kayahara M; Ninomiya I; Fushida S; Fujimura T; Nishimura G; Shimizu K; Miwa K Int J Oncol; 2004 Mar; 24(3):679-85. PubMed ID: 14767553 [TBL] [Abstract][Full Text] [Related]
4. The histone deacetylase inhibitor FR901228 induces caspase-dependent apoptosis via the mitochondrial pathway in small cell lung cancer cells. Doi S; Soda H; Oka M; Tsurutani J; Kitazaki T; Nakamura Y; Fukuda M; Yamada Y; Kamihira S; Kohno S Mol Cancer Ther; 2004 Nov; 3(11):1397-402. PubMed ID: 15542778 [TBL] [Abstract][Full Text] [Related]
5. Effects of histone deacetylase inhibitor FR901228 on the expression level of telomerase reverse transcriptase in oral cancer. Murakami J; Asaumi J; Kawai N; Tsujigiwa H; Yanagi Y; Nagatsuka H; Inoue T; Kokeguchi S; Kawasaki S; Kuroda M; Tanaka N; Matsubara N; Kishi K Cancer Chemother Pharmacol; 2005 Jul; 56(1):22-8. PubMed ID: 15791453 [TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase inhibitor FR901228 enhances the antitumor effect of telomerase-specific replication-selective adenoviral agent OBP-301 in human lung cancer cells. Watanabe T; Hioki M; Fujiwara T; Nishizaki M; Kagawa S; Taki M; Kishimoto H; Endo Y; Urata Y; Tanaka N; Fujiwara T Exp Cell Res; 2006 Feb; 312(3):256-65. PubMed ID: 16356494 [TBL] [Abstract][Full Text] [Related]
7. P21-dependent g(1)arrest with downregulation of cyclin D1 and upregulation of cyclin E by the histone deacetylase inhibitor FR901228. Sandor V; Senderowicz A; Mertins S; Sackett D; Sausville E; Blagosklonny MV; Bates SE Br J Cancer; 2000 Sep; 83(6):817-25. PubMed ID: 10952788 [TBL] [Abstract][Full Text] [Related]
8. FR901228, a potent antitumor antibiotic, is a novel histone deacetylase inhibitor. Nakajima H; Kim YB; Terano H; Yoshida M; Horinouchi S Exp Cell Res; 1998 May; 241(1):126-33. PubMed ID: 9633520 [TBL] [Abstract][Full Text] [Related]
9. Role of hTERT in apoptosis of cervical cancer induced by histone deacetylase inhibitor. Wu P; Meng L; Wang H; Zhou J; Xu G; Wang S; Xi L; Chen G; Wang B; Zhu T; Lu Y; Ma D Biochem Biophys Res Commun; 2005 Sep; 335(1):36-44. PubMed ID: 16051188 [TBL] [Abstract][Full Text] [Related]
10. Depsipeptide (FR901228) inhibits proliferation and induces apoptosis in primary and metastatic human uveal melanoma cell lines. Klisovic DD; Katz SE; Effron D; Klisovic MI; Wickham J; Parthun MR; Guimond M; Marcucci G Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2390-8. PubMed ID: 12766035 [TBL] [Abstract][Full Text] [Related]
11. Romidepsin (depsipeptide) induced cell cycle arrest, apoptosis and histone hyperacetylation in lung carcinoma cells (A549) are associated with increase in p21 and hypophosphorylated retinoblastoma proteins expression. Vinodhkumar R; Song YS; Devaki T Biomed Pharmacother; 2008 Feb; 62(2):85-93. PubMed ID: 17644301 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of telomerase activity and human telomerase reverse transcriptase gene expression by histone deacetylase inhibitor in human brain cancer cells. Khaw AK; Silasudjana M; Banerjee B; Suzuki M; Baskar R; Hande MP Mutat Res; 2007 Dec; 625(1-2):134-44. PubMed ID: 17669439 [TBL] [Abstract][Full Text] [Related]
13. Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571. Wang WL; Healy ME; Sattler M; Verma S; Lin J; Maulik G; Stiles CD; Griffin JD; Johnson BE; Salgia R Oncogene; 2000 Jul; 19(31):3521-8. PubMed ID: 10918610 [TBL] [Abstract][Full Text] [Related]
14. Telomerase expression and cell proliferation in ovarian cancer cells induced by histone deacetylase inhibitors. Zhu K; Qu D; Sakamoto T; Fukasawa I; Hayashi M; Inaba N Arch Gynecol Obstet; 2008 Jan; 277(1):15-9. PubMed ID: 17680259 [TBL] [Abstract][Full Text] [Related]
15. Reduction of telomerase activity in human liver cancer cells by a histone deacetylase inhibitor. Nakamura M; Saito H; Ebinuma H; Wakabayashi K; Saito Y; Takagi T; Nakamoto N; Ishii H J Cell Physiol; 2001 Jun; 187(3):392-401. PubMed ID: 11319763 [TBL] [Abstract][Full Text] [Related]
16. Enhanced adenovirus transgene expression in malignant cells treated with the histone deacetylase inhibitor FR901228. Kitazono M; Goldsmith ME; Aikou T; Bates S; Fojo T Cancer Res; 2001 Sep; 61(17):6328-30. PubMed ID: 11522619 [TBL] [Abstract][Full Text] [Related]
17. The histone deacetylase inhibitor FR901228 (desipeptide) restores expression and function of pseudo-null p53. Kitazono M; Bates S; Fok P; Fojo T; Blagosklonny MV Cancer Biol Ther; 2002; 1(6):665-8. PubMed ID: 12642691 [TBL] [Abstract][Full Text] [Related]
18. Apoptosis induced by the histone deacetylase inhibitor FR901228 in human T-cell leukemia virus type 1-infected T-cell lines and primary adult T-cell leukemia cells. Mori N; Matsuda T; Tadano M; Kinjo T; Yamada Y; Tsukasaki K; Ikeda S; Yamasaki Y; Tanaka Y; Ohta T; Iwamasa T; Tomonaga M; Yamamoto N J Virol; 2004 May; 78(9):4582-90. PubMed ID: 15078940 [TBL] [Abstract][Full Text] [Related]
20. Adenovirus-mediated p53 gene transduction inhibits telomerase activity independent of its effects on cell cycle arrest and apoptosis in human pancreatic cancer cells. Kusumoto M; Ogawa T; Mizumoto K; Ueno H; Niiyama H; Sato N; Nakamura M; Tanaka M Clin Cancer Res; 1999 Aug; 5(8):2140-7. PubMed ID: 10473098 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]